Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin and methylprednisolone for vertigo in Ménière's disease
IRCT2015041021582N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of gentamicin and methylprednisolone in Meniere Disease (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Nov 2014; status: completed.
02
Drugs
gentamicinmethylprednisolone
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on IRCT2015041021582N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015041021582N1.